David R D'Adamo Selected Research

Drug Tapering

1/2019

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R D'Adamo Research Topics

Disease

10	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 10/2005
9	Neoplasms (Cancer) 01/2021 - 01/2006
4	Disease Progression 01/2019 - 12/2008
3	Leiomyosarcoma 01/2019 - 10/2017
2	Liposarcoma 01/2019 - 10/2017
2	Synovial Sarcoma (Synovioma) 01/2019 - 01/2013
2	Neurofibrosarcoma (MPNST) 01/2019 - 07/2009
2	Hemangiosarcoma (Angiosarcoma) 07/2012 - 07/2009
2	Fibroma (Fibromatosis) 06/2011 - 05/2010
2	Aggressive Fibromatosis (Desmoid) 06/2011 - 05/2010
1	Triple Negative Breast Neoplasms 01/2021
1	Fever (Fevers) 01/2019
1	Hypersensitivity (Allergy) 01/2013
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2013
1	Testicular Neoplasms (Testicular Cancer) 01/2013
1	Chondrosarcoma 10/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2011
1	Clear Cell Sarcoma 09/2011
1	Solitary Fibrous Tumors 07/2009
1	Giant Cell Tumor of Bone 07/2009
1	Extraskeletal Myxoid Chondrosarcoma 12/2008
1	Cardiotoxicity 10/2005

Drug/Important Bio-Agent (IBA)

3	eribulin FDA Link 01/2021 - 10/2017
3	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 10/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2012 - 10/2005
2	Bevacizumab (Avastin)FDA Link 01/2015 - 10/2005
2	AnthracyclinesIBA 07/2012 - 05/2010
1	B7-H1 AntigenIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2019
1	Gemcitabine FDA Link 01/2015
1	Docetaxel (Taxotere)FDA Link 01/2015
1	IpilimumabIBA 01/2013
1	AntigensIBA 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2012
1	Taxoids (Taxanes)IBA 07/2012
1	alvocidib (flavopiridol)IBA 05/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2012
1	PlatinumIBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Biological ProductsIBA 01/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2011
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2011
1	CrizotinibIBA 10/2010
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2010
1	Phosphotransferases (Kinase)IBA 07/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009
1	Sunitinib (Sutent)FDA Link 07/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2006
1	Dexrazoxane (Zinecard)FDA LinkGeneric 10/2005

Therapy/Procedure

7	Therapeutics 01/2021 - 07/2009
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
1	Immunotherapy 01/2021
1	Drug Tapering 01/2019